申请人:Brown Matthew Frank
公开号:US20120202777A1
公开(公告)日:2012-08-09
The present invention is directed to a new class of hydroxamic acid derivatives of Formula I,
wherein the variables G, T, D, L, A, X, R
1
and R
2
are as described hereinabove, and their use as LpxC inhibitors, and more specifically their use to treat bacterial infections.
本发明涉及一种新的羟肟酸衍生物类别,其化学式为I,其中变量G、T、D、L、A、X、R1和R2如上所述,并且它们作为LpxC抑制剂的用途,更具体地用于治疗细菌感染。